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Cisplatin7,8-Dihydro-8-oxoguanine (8-oxoG) is one of the most common oxidative base lesions in normal tissues
induced by a variety of endogenous and exogenous agents. Hydantoins are products of 8-oxoG oxidation
and as 8-oxoG, they have been shown to be mutagenic lesions. Oxidative DNA damage has been implicated
in the etiology of various age-associated pathologies, such as cancer, cardiovascular diseases, arthritis, and
several neurodegenerative diseases. The mammalian endonuclease VIII-like 3 (Neil3) is one of the four
DNA glycosylases found to recognize and remove hydantoins in the ﬁrst step of base excision repair (BER)
pathway. We have generated mice lacking Neil3 and by using total cell extracts we demonstrate that Neil3
is the main DNA glycosylase that incises hydantoins in single stranded DNA in tissues. Using the neurosphere
culture system as a model to study neural stem/progenitor (NSPC) cells we found that lack of Neil3 impaired
self renewal but did not affect differentiation capacity. Proliferation was also reduced in mouse embryonic
ﬁbroblasts (MEFs) derived from Neil3−/− embryos and these cells were sensitive to both the oxidative
toxicant paraquat and interstrand cross-link (ICL)-inducing agent cisplatin. Our data support the involve-
ment of Neil3 in removal of replication blocks in proliferating cells.
© 2013 Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Oxidative DNA damage is generated by a variety of reactive oxygen
species (ROS), which are produced through normal cellular metabolism
and by various environmentalmutagens and dietary factors [1]. Oxidative
DNA lesions are of signiﬁcant interest, due to their implications in
mutagenesis, carcinogenesis, aging, and neurodegeneration [2–6]. These
lesions are repaired via the base excision repair (BER) pathway which
recognizes and removes damaged bases from DNA [7,8]. Mammalian
cells possess at least ﬁve DNA glycosylases with overlapping substrate
speciﬁcity that recognize and remove oxidative DNA lesions: OGG1/
Ogg1, NTHL1/Nthl1 and three E. coli Fpg and Nei orthologs inmammalian
cells, named NEIL1,2,3/Neil1, 2 and 3 [7,8]. The prevalent oxidative DNA
lesion, 7,8-dihydro-8-oxoguanine (8-oxoG) is subject to further oxidation
to form the hydantoin products spiroiminodihydantoin (Sp) and
guanidinohydantoin (Gh) [9–13]. The hydantoin lesions have been
shown in vitro and in vivo to be highly mutagenic [14]. Sp and Gh47 23 07 40 61.
versity of Oslo, Oslo University
Oslo, Norway.
-NC-ND license.are removed by NTHL1/Nthl1 and the NEILs/Neils but not by OGG1/
Ogg1 [15–20].
DNA glycosylases are widely expressed in all organs and in most
cells; conversely NEIL3/Neil3 has a characteristic expression pattern
limited to a few organs and speciﬁc cells [21–31]. Human NEIL3 is
highly expressed in thymus and testis, in tumor tissues and in highly
proliferative cells [24,30,32]. Mouse Neil3 is highly expressed in he-
matopoietic tissue, during embryonic development and in stem/
progenitor rich regions in the brain such as the subventricular zone
and the dentate gyrus of hippocampus [27,29,30]. Targeted deleted
mice have been generated for Ogg1, Nthl1, Neil1 and Neil3 and
share the fact that they are viable, fertile and with only subtle pheno-
types as single or even double knock outs [27,33–39]. However, expo-
sure of these mice toward insults such as brain ischemia has started
to reveal various detrimental effects [39–41].
In this paper we demonstrate that Neil3 is the key enzyme in cell
extracts for removal of hydantoins in single stranded context. Further,
there are no major differences in the brain anatomy of newborn
Neil3+/+ and Neil3−/− animals. However, using the neurosphere assay
to study neural/progenitor stem cell (NSPC) behavior in vitro, we
showed that self renewal but not differentiation capacity was affected
in Neil3−/− derived neurospheres. Finally, Neil3 loss sensitizes mouse
Table 1
Primers used in real-time qRT-PCR.
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the interstrand cross-link (ICL)-inducing agent cisplatin.Target Sequence 5′→3′ Acc. nr.
Nhtl1 Right primer: TGGTCCACCTCAGTCTGTTG NM_008743
Left primer: CACACTTGGCTATGGCTGTG
Neil1 Right primer : GAGATCCTGTACCGGCTGAAGA NM_028347
Left primer : GGTTCTGTAGTTTGGCCTTGATCT
Neil2 Right primer: TTCCCTGTATAGGCTGTGGG NM_201610
Left primer : GTCTCTGTGGCTCCAGGATG
Neil3 Right primer: GGGCAACATCATCAAAAATGAA NM_146208
Left primer : CTGTTTGTCTGATAGTTGACACACCTT
Gapdh Right primer: CCAAGGTCATCCATGACAACTT2. Materials and methods
2.1. Animals
Neil3 KO mice were generated as previously described [39].
Experimental procedures were approved by the Norwegian Animal
Research Authority.Left primer : AGGGGCCATCCACAGTCTT2.2. DNA glycosylase assay
Whole-cell protein extracts from Neil3+/+ and Neil3−/− were
made from brain, heart, thymus and spleen of newborn mice. The or-
gans were ﬁrst scalpel macerated and then homogenized in lysis buff-
er (50 mMMOPS, 200 mMKCl, 0,1% Triton X-100, 1 mM EDTA, 1 mM
DTT, and 2 mM PMSF) using a motorized pestle. After 30 min incuba-
tion on ice, the extracts were frozen on ethanol–dry ice/thawed at
30 °C three times. Cell debris was removed by 15 min centrifugation
at 13,000 rpm. The protein concentration was measured using Bradford
assay.
Oligonucleotides containing the base lesions: 5-ohC (5′gcatgcctgcacgg
[5-ohC]catggccagatccccgggtaccgag3′) (Operon), Sp or Gh (5′tgttcatcatgcg
tc[Gh/Sp]tcggtatatcccat3′) (a kind gift from Prof. Cynthia J. Burrows, De-
partment of Chemistry, University of Utah) were 32P-endlabeled by T4
PNK (New England Biolabs) and [γ-32P]adenosine triphosphate (Perkin
Elmer) by incubation for 30 min at 37 °C. PNKwas inactivated by heating
at 80 °C. Complementary oligonucleotides, containing a C opposite Gh
and Sp or a G opposite 5-ohC were annealed by heating the sample
to 90 °C for 2 min followed by slow cooling to room temperature to
generate double stranded substrates. The oligonucleotides were puriﬁed
by 20% native polyacrylamide gel electrophoresis, visualized by
phosphorimaging (Typhoon 9410 (Molecular Dynamics)), isolated from
the gel, eluted in dH2O and stored at 4 °C. Incision activities were assayed
in a 10 μl reaction mixture containing 10 fmol radiolabeled substrate,
50 mM MOPS pH 7.5, 1 mM EDTA, 5% glycerol, 1 mM DTT and 4 μg
whole-cell protein extracts at 37 °C for 60 min. The enzymatic reaction
was terminated by adding 10 μl formamide solution (80% formamide,
10 mM EDTA, bromophenol blue and xylene cyanol) and analyzed on
20% polyacrylamide/7 M urea gel followed by phosphorimaging. Incision
activity was calculated using the ImageQuant v5.0 software (Molecular
Dynamics).2.3. Total RNA isolation, cDNA synthesis and real-time qRT-PCR
Total RNA was isolated from Neil3+/+ and Neil3−/− brain, heart,
thymus and spleen of newborn mice using the RNeasy minikit
(Qiagen) following the manufacturer's instructions. The RNA was fur-
ther puriﬁed by phenol/chloroform extraction and RNA was treated
with TurboDNase (Applied Biosystems). The purity of RNA was con-
trolled by absorbance (260/280 nm and 260/230 nm) measurements
using Nanodrop Spectrophotometer. cDNA was synthesized from
50 ng RNA in 20 μl reaction samples using the High-Capacity cDNA
Reverse Transcription kit (Applied Biosystems). Real-time qRT-PCR
was performed in 20-μl reactions containing 10 ng of cDNA and
100 nM primers using the Power SYBR Green PCR master mix and
the Step One Plus real-time PCR system (Applied Biosystems)
according to the system and kit instructions. The expression of
Gapdh was used as endogenous control and standard curves for
primers were assayed on each plate. Relative gene expression was
calculated using the relative standard curve method. The experiment
was performed three times with RNA isolated from three different
mice. All samples were run in triplicates. Primers are listed in Table 1.2.4. Immunohistochemistry
Neil3+/+ and Neil3−/− P0 mice were transcardially perfused with
PBS and then 4% PFA. For BrDU analysis, newborn mice were injected
intraperitonal with 100 μg/gram bodyweight BrdU (Sigma) in PBS
(room temperature) 2 h before perfusion. Brains were removed and
post ﬁxed in PFA for at least 24 h at 4 °C before being dehydrated
and embedded in parafﬁn. Sagittal sections of 4 uM were cut on a
microtome and sections from the same brain area of Neil3+/+ and
Neil3−/− were placed on the same glass slides to secure equal immu-
nohistochemistry procedure for both genotypes. Antigen retrieval
was performed using citrate buffer, pH 6.0, and heating for 20 min
in a microwave oven. Sections were blocked with 5% BSA and 5%
goat serum in PBS with 0.1% Tween for 1 h before treatment with
primary antibody for 24 h at 4 °C in 0.5% goat serum, 0.5% BSA, and
in PBS with 0.1% Tween. After washing in 0.1% Tween in PBS the
sections were treated with secondary antibody for 1 h at room
temperature. For BrdU staining, DNA was denatured with 1 M HCl
for 10 min on ice and then in 2 M HCl 10 min in room temperature
and further incubation for 20 min at 37 °C. Then the sections were
neutralized in PBS before blocking. Nuclei were counterstained with
DAPI (Sigma). Sections were visualized using an Axioplan2 Zeiss
ﬂuorescence microscope and BrDU cells were quantiﬁed with ImageJ
(National Institutes of Health).
Neil3+/+ and Neil3−/− neurospheres derived from newborn
whole brain were pelleted, suspended in plasma and thrombine at
day 7 after 2nd passage, ﬁxated, dehydrated, parafﬁn embedded,
sectioned and stained. Staining was performed as described above.
The primary antibodies used were: mouse anti-Nestin 1:200
(MAB353,Millipore);mouse anti-GFAP1:400 (G9838; Invitrogen); rabbit
anti-doublecortin 1:2000 (ab18723; AbCam); mouse anti-doublecortin
1:500 (611706; BD Transduction); mouse anti-β-tubulin subtype III
(Tuj1) 1:100 (MAB1195; R&D Systems) and rat anti-BrdU 1:1000
(ab6326; AbCam). Secondary antibodies used were Alexa Fluor 594
anti-mouse, Alexa Fluor 488 anti-rabbit and Alexa Fluor 594 anti-rat at
1:500 dilutions (Molecular Probes/Invitrogen).
2.5. Neurosphere propagation, colony forming assay and differentiation
Neurosphereswere prepared fromNeil3+/+ andNeil3−/− forebrains
of newborn mice, cultured and propagated as previously described,
with some modiﬁcations [42,43]. Cells were cultured in serum free
Neurobasal-A medium (Gibco/Invitrogen) supplemented with 2%
B-27 (Gibco), 2 mM glutamine (GlutaMAX; Gibco) and penicillin/
streptomycin (Pen-Strep 100X; MP Biomedicals Fisher Scientiﬁc),
20 ng/ml hEGF (R&D Systems) and 10 ng/ml hFGF-2 (MACS; Milteney
Biotech) at a concentration of 20,000 live cells/ml. Neurosphere cul-
tures were grown for 7 days and then trypsinized and ﬁltered through
a 70 uM mesh before being resuspended in medium for propagation,
exposure experiments, colony forming assays and differentiation.
For colony forming assays, single cells were seeded into 96 well
plates at 500 cells per well and grown for 11 days before colonies
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were counted.
For differentiation, single cells from spheres were plated in 24 well
poly-L-lysine coated plates at a concentration of 150,000 cells/ml in
medium without EGF and incubated for 5 days. Cells were ﬁxed in
4% PFA for 10 min, permeabilized with 0.1% Triton X-100 in PBS for
10 min and stained with Nestin, GFAP, Tuj1 and DCX as described
for immunohistochemistry. Cells were analyzed in a Zeiss Axiovert
200M Microscope using AxioVision 4.6 software.
2.6. Primary mouse embryonic ﬁbroblasts and exposure experiments
Primary mouse embryonic ﬁbroblasts (MEFs) were generated from
15,5 days old Neil3+/+ and Neil3−/− embryos. Limbs were removed
from embryos and the tissue was chopped into small pieces and cell
suspension was made using a pipette. MEFs were grown in DMEM
medium (Gibco/Invitrogen) supplemented with 10% serum, 2 mM
glutamine (GlutaMAX, Gibco) and penicillin/streptomycin as before
(complete medium). Cells grown for 7–8 days were trypsinized and
frozen down in complete medium with 10% DMSO as stock. Frozen
aliquots were taken up and grown in complete medium for 2–4 days
before using them for proliferation capacity and survival assays.
Primary MEF cells were seeded in 96 well plates at a concentration
of 10 000 cells/well, incubated for 4 h and treated with 0, 25, 50 and
75 μM paraquat or 0, 5, 10 and 20 μM of cisplatin for 24 h. 5 mg/ml
MTT was added to cells for 4 h and then 100 μl solubility solution
was added to each well and incubated at 37 °C over night before mea-
surement of OD at 590 and 670. Results are presented as 590–670 OD
minus OD for only medium, % of control.
3. Results
3.1. Impaired removal of hydantoins in tissues of newborn Neil3−/−mice
The expression of Neil1,Neil2,Neil3 andNthl1 has been examined by
different methods in various tissues, during embryonic development
and at different ages [27,29,30,44]. In this report we have investigated
by real-time qRT-PCR the levels of Neil1, Neil2, Neil3 and Nthl1 in thy-
mus, spleen, heart and brain from Neil3+/+ and Neil3−/− newborn
mice (Fig. 1A). As seen in Fig. 1A, Neil3was highly expressed in thymus
and spleen, but barely detected in Neil3+/+ brain and heart. In contrast,
the expression levels of Neil1 and Neil2 were relatively high in thymus
compared to the rest of the organs investigated. For Nthl1, the expres-
sion was more homogeneous with spleen having the highest levels
(Fig. 1A).
To investigate the effects of Neil3 disruption, nicking activities for
single and double stranded Gh and Sp and double stranded 5-ohC
were measured in total cell extracts from newborn Neil3+/+ and
Neil3−/− thymus, spleen, heart and brain. As seen in Fig. 1B, nicking
activity on double stranded substrateswas readily detected in all tissues
and there was no difference between Neil3+/+ and Neil3−/−. Nicking
activity on single stranded substrates was persistently lower compared
to the nicking activity on double stranded substrates in all tissues.
Notably, the incision activity on single stranded Sp and Ghwas reduced
in all the Neil3−/− extracts as compared to Neil3+/+ extracts. To investi-
gate whether the activity on single stranded hydantoins was derived pri-
marily from the Neil3 protein we performed a sodium cyanoborohydride
(NaCNBH3) trapping assay. This reagent reduces the Schiff base interme-
diate and provokes the formation of a stable cross-link between enzyme
and DNA. The DNA–protein complex can be visualized as a band on
SDS/PAGE gels [45,46].Migration of theDNA–protein complexes depends
on the size of the protein and the nature of the DNA substrate. We tested
fractions of puriﬁed full-length NEIL3 (MW: 68 kDa), core-NEIL3 (MW:
34 kDa) [47] and puriﬁed E. coli Fpg (MW: 30.2 kDa, Nei (MW:
29.7 kDa) and Nth (MW: 23 kDa) in the borohydride-dependent trap-
ping assay to AP site-containing ssDNA. The slowest migrating bandcorresponded to the 68 kDa partially puriﬁed full-length NEIL3, while
the faster migrating bands corresponded to the 23–34 kDa core-NEIL3,
and E. coli Fpg, Nei and Nth proteins (Supplementary Fig. S1). For the
double-stranded substrates, there were several bands indicating the
presence of different trapped proteins, however the slowest migrating
band was absent in the Neil3−/− extracts (Fig. 1C). For the single-
stranded substrates fewer bands were detected and again, the slowest
migrating band was absent in the Neil3−/− extracts (Fig. 1C). A size
difference on the trapped bands between ss and ds substrates was
observed. Such migrating differences have been observed for puriﬁed
NEIL1 and NEIL2 in similar trapping experiments using Sp and Gh sub-
strates in ss and ds contexts [16]. These results indicated that the slowest
migrating band observed in the Neil3+/+ extracts corresponded to the
Neil3–DNA complex. Both the expression analysis and activity assays
presented support the conclusion that Neil3 was the main enzyme
responsible for the removal of hydantoins in single stranded substrates.
3.2. Neil3 loss does not affect brain size or architecture
In light of the restricted pattern of Neil3 expression during mouse
brain embryonic development we set out to examine the morphology
and cellular composition of P0 brains isolated from Neil3+/+ and
Neil3−/−mice. At this stage, neurogenesis,which begins early in embry-
onic life, is largely complete, however, in certain locations neurogenesis
persists into adulthood and anymajor defect in the structural organiza-
tion can be readily detected [48–50].
To investigate the cellular composition and differentiation pattern,
we analyzed serial sagittal sections with various antibodies speciﬁc for
various stages of differentiation: nestin, an intermediate ﬁlament pro-
tein found in noncommitent NSCs and GFPA an intermediate ﬁlament
in astrocytes. There was no difference in the expression of the tested
antibodies between Neil3−/− and Neil3+/+ P0 brains (Fig. 2A).
To investigate the proliferation state, we used four differentmarkers
with speciﬁcity in different cell cycle phases: BrdU, 5-bromo-
2-deoxyuridine, a thymidine analogue that is incorporated into DNA
during the S-phase of the cell cycle [51]; Ki67, a nuclear antigen
which is expressed in all cell cycle phases except for G0 [52,53]; PCNA,
the proliferating cell nuclear antigen, a non-histone protein associated
with the DNA polymerase [54]; and pHH3, the phosphorylated histone
H3, amarker for G2/Mof the cell cycle [55]. No differences could be seen
with any of these markers in the dentate gyrus of the hippocampus
(Fig. 2B, example of BrdU) or in the walls of the lateral ventricles
(data not shown) between the two genotypes. In summary, we did
not detect any effect of Neil3 deﬁciency on gross brain morphology,
cell composition or state of proliferation in the P0 animals.
3.3. Neurospheres from forebrain of Neil3−/− newborn mice exhibit
reduced proliferation but have normal differentiation capacity
We next established neurosphere cultures from forebrain of
Neil3+/+ and Neil3−/− newborn mice and examined neurosphere
composition, self-renewal and differentiation capacity. Neil3+/+ and
Neil3−/− neurospheres exhibited typical morphology of densely
packed cells with a regular rim and well deﬁned spherical shape
and were of equal size. To investigate whether there was a difference
between the composition of Neil3+/+ and Neil3−/− neurospheres,
immunohistochemical phenotypization was carried out. As seen in
Fig. 3, no differences were detected with the antibodies used; Nestin,
Tuj1, GFAP and DCX, doublecortin, a microtubule-associated protein
transiently expressed in proliferating andmigrating neuronal progen-
itors during development [56,57].
To assess self-renewal capability,Neil3+/+ andNeil3−/−neurospheres
were serially dissociated into single cells to generate secondary, tertiary
and up to septenary neurospheres. The Neil3−/− derived neurospheres
formed fewer spheres suggesting that the self-renewing activity was im-
paired (Fig. 4A). To examine multipotentiality, we analyzed the effect of
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1160 V. Rolseth et al. / Biochimica et Biophysica Acta 1833 (2013) 1157–1164Neil3 loss on differentiation using an in vitro differentiation assay, where-
by single-cell suspensions from secondary or higher passages were
induced to differentiate when plated at a high density in adherent condi-
tions in the absence of EGF for 5 days. The cells were immunostained to
assess the differentiation into immature neurons (Tuj1) and astrocytes
(GFAP) (Fig. 4B). We noted no differences between the two genotypes.
3.4. Proliferation of Neil3−/− primary embryonic ﬁbroblasts is abridged
and show sensitivity toward DNA damaging agents
Proliferation capacity and cell survival was examined in primary
MEFs derived from E15.5 Neil3+/+ and Neil3−/− embryos. We ﬁrst
examined the proliferative capacity of Neil3+/+ and Neil3−/− primary
MEFs and detected a diminished proliferative capacity of the Neil3−/−
primary MEFs (Fig. 5A). As NEIL3 has been shown to partially comple-
ment an E. coli nth nei double mutant strain sensitive to hydrogenperoxide [31] we therefore wanted to test whether the absence of
Neil3 would sensitize cells to different genotoxic stress. As shown in
Fig. 5B, primary Neil3−/− MEFs were more sensitive to paraquat
than primary Neil3+/+ MEFs supporting the notion that Neil3 is
involved in repair of oxidative DNA lesions. Surprisingly, primary
Neil3−/−MEFs were more sensitive to cisplatin than primary Neil3+/+
MEFs, indicating a role in DNA crosslink repair.
4. Discussion
In this reportwe present evidence that in vivo, Neil3 is themain DNA
glycosylase for the removal of hydantoins in single stranded substrates
in four different tissues derived from newborn mice. Neil3+/+ and
Neil3−/− total cell extracts displayed no difference in the incision of
double stranded substrates containing hydantoins, however incision
in the single stranded context was reduced in the Neil3−/− extracts.
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different substrate contexts by the NEIL recombinant proteins. To sum
up the results of various reports: NEIL1 is more efﬁcient in removing
hydantoins relative to other oxidized bases particularly in doubleA
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1162 V. Rolseth et al. / Biochimica et Biophysica Acta 1833 (2013) 1157–1164a partially puriﬁed full length Neil3 protein [18,58]. These results
showed that the enzymes were almost as active in hydantoin
containing single- and double-stranded substrates. For endogenous
NEIL3, we recently reported DNA incision activity on single stranded
Gh substrate, however to our knowledge, this is the only report on the
activity of any of the endogenous NEILs/Neils [32]. The incision activity
results presented in this paper using Neil3+/+ and Neil3−/− total cell
extracts clearly showed that Neil3 is the main DNA glycosylase that
incises Sp or Gh single stranded substrates.Fig. 5. Neil3−/− primary MEFs exhibited reduced proliferation and were sensitive toward pa
with 5000 cells seeded in wells of 96 well plates (6 triplicates for each genotype). Results are
of Neil3−/− and Neil3+/+ primary MEFs treated with increasing amounts of paraquat and cThe lack of Neil3 did not affect the overall macroscopic organization
or size of the brain nor didNeil3 deﬁciency appear to have amajor effect
on proliferation or composition in the DG of the hippocampus or in the
SVZ. Nevertheless, Neil3−/− derived neurospheres enriched for NSPCs
exhibited reduced proliferation but normal capacity to differentiate
under unstressed conditions. Decreased proliferative capacity has also
been observed for neurospheres derived from the SVZ of 18 month
Neil3−/− animals and in rat E15.5 (corresponding to mouse E13.6)
derived neurospheres in which Neil3 was knocked down [59,60].raquat and cisplatin treatment. (A) MTT assay of Neil3−/− and Neil3+/+ primary MEFs
mean OD (% of control) of three independent experiments. *** pb0.0005. (B) MTT assay
isplatin.
1163V. Rolseth et al. / Biochimica et Biophysica Acta 1833 (2013) 1157–1164In contrast to our differentiation results, the expression of neuronal
and astrocytic genes decreased in siNeil3 neurospheres compared to
controls [60]. This discrepancy can be due to several differences
between the experimental set up. The neurospheres were made by
different methods and at different time points. Interestingly, siNeil3
neurospheres were made at a time corresponding in mice were there
are high numbers of Neil3 positive cells as compared to newborn. This
might inﬂuence the differentiation capacity. Second, the differentiation
of the rat neurospheres has been enhancedwith the addition of valproic
acid which we did not use. There is now experimental evidence linking
valproic acid to the generation of oxidative stress [61]. Thus, differenti-
ation deﬁciency observed in siNeil3 neurospheres can be due to the
treatment with valproic acid producing oxidative stress. Similarly,
differentiation deﬁciency was observed for Neil3−/− neurospheres
derived from brain subjected to ischemic insult [39]. Finally, differenti-
ation has been assessed in different ways. We looked at the number of
cells expressing different markers while the other report uses quantita-
tive RT-PCR to assess differentiation.
Neil3−/−MEFs were sensitive toward paraquat and cisplatin. Both
paraquat and cisplatin have been shown to induce oxidative stress;
however the DNA damage spectra are quite different [62–64].
Cisplatin interacts with nucleophilic N7-sites of purine bases in DNA
to form DNA interstrand (ICL) crosslinks [65,66]. The repair of ICls
requires the interplay of multiple pathways including nucleotide
excision repair, homologous recombination, mismatch repair, Fanconi
anemia signaling pathway and translesion synthesis [67,68]. NEIL1
has been shown to excise bulky psoralen-induced ICLs implicating
BER in the repair of ICLs [69–71]. The authors proposed a model
for replication-associated repair of psoralen-induced ICLs in which
NEIL1 has a role excising the unhooked fragment in a three-stranded
DNA structure [70]. Similarly, as (i) NEIL3 is highly expressed in S
phase [32]; (ii) Neil3 excises base lesions in single stranded context;
(iii) Neil3−/− MEFs are sensitive toward cisplatin treatment and
(iv), the expression of Neil3 has been shown to be upregulated in
breast cancer cells after cisplatin treatment [72], we would like to ex-
tend the suggested model to include Neil3 in replication-associated
repair of cisplatin-induced ICLs. Additional experiments have to be
done to elucidate the types of damage and the proteins involved in
such a model.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamcr.2012.12.024.Acknowledgements
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